JPRN-jRCTb070200022招募中2 期
The treatment using Adipose-Derived Regenerative Cells; ADRCs for urinary incontinence - ADRCUI
Mukouyama Hideki0 个研究点目标入组 10 人开始时间: 2020年7月21日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- Male
入选标准
- •(1)Patients over the age of 20
- •(2)Patients with post-prostatectomy stress urinary incontinence who is not able to have effect by medical treatments
- •(3)Post-prostatectomy patients who have not had a recurrence of prostate cancer in two years
- •(4)Patients who have provided a written informed consent to participate in this research
- •(5)Patient who has sufficient amount of adipose in the area of abdomen, lumber, or femoral region. This is to be confirmed by CT Scan (Plain/Supine Position) where adipose is to be collected.
排除标准
- •(1)Patients with infectious diseases
- •(2)Patients with fever symptoms
- •(3)Patients with severe complications; heart disease, pulmonary disease, liver disease, kidney disease (creatinine 3.0 and above), bleeding tendency, severe anemia, uncontrolled diabetes, high blood pressure
- •(4)Patients who are currently on a large amount of steroids or immunosuppressive agents
- •(5)Patients with past medical history of drug hypersensitivity
- •(6)Patients with malignant tumors who are receiving chemotherapy, radiation therapy, and other cancer treatments.
- •(7)Patients who are not able to be evaluated properly due to cognitive problems
- •(8)Patients who are carriers of either HBV, HCV, HIV, and HTLV-1 or who are already at onset of the disease.(excluding cured pre-infected patients)
- •(9)Patients who are determined unfit for the treatment by principal investigator or sub investigator
研究者
相似试验
已完成
不适用
clinical results of adipose-derived regenerative cell therapy for osteoarthritisosteoarthritisJPRN-UMIN000033510Kanazawa University50
进行中（未招募）
不适用
A clinical evaluation of adipose derived Regenerative cells in the treatment of patients with brEast deformities post Segmental breast resection (lumpectomy) with Or without Radiation therapy. A phase IV post market study – the RESTORE 2 trialEvaluación clínica de células regenerativas derivadas de tejido adiposo para el tratamiento de pacientes con deformidades mamarias tras mastectomia segmentaria (cuadrantectomia) con o sin radioterapia. Un ensayo fase IV de farmacovigilancia – Ensayo RESTORE -2 - RESTORE-2Pacientes con deformidades mamarias tras mastectomía segmentaria (cuadrantectomía) con o sin radioterapiaEUCTR2007-007956-33-ESCytori Therapeutics Inc70
进行中（未招募）
1 期
Stem cells in the treatment of burnsSkin burns.MedDRA version: 20.0Level: LLTClassification code 10039798Term: Second degree burnsSystem Organ Class: 100000004863EUCTR2018-002870-27-DKDept. of Plastic Surgery and Burns Treatment, Copenhagen University Hospital Rigshospitalet20
已完成
2 期
Safety and Feasibility Trial of Adipose-Derived Regenerative Cells in the Treatment of Chronic Myocardial IschemiaMyocardial IschemiaNCT01556022Cytori Therapeutics28
已完成
2 期
Safety & Efficacy of Adipose-Derived Regenerative Cells in the Treatment of Chronic Myocardial Ischemia (ATHENA II)Myocardial IschemiaNCT02052427Cytori Therapeutics3